- 68.8k views
Understanding Preganancy 101 Teratology and drugs in Pregnancy
A teratogen is an agent that can disturb the development of the embryo or Fetus. The clinical consequences of drug teratogens lead to developmental defects in humans. Defects may be due to genetic, environmental, or unknown causes. Drug use is an uncommon cause of birth defects, but certain medications can increase the risk of developing a birth defect. Join the Case Based discussion with Dr Aruna Reddy Senior Gynecologist and Head OBG Department to have an exclusive learning on Teratology and drugs in Pregnancy.
About the Speaker
Dr Aruna Reddy
Senior Gynecologist and Head OBG department Giggles Omni kukatpally Hyderabad at OMNI Hospitals
Upcoming Case Discussions
Pediatric and Adult Veneers: Case Studies
Pediatric dental veneers can be transformative in restoring smiles and dental function in children with various dental issues. Case studies illustrate the efficacy and benefits of veneers in pediatric dentistry. They might showcase how veneers can improve the appearance of discolored or malformed teeth, enhancing a child's self-esteem. They might also demonstrate how veneers can correct dental imperfections caused by injury or developmental abnormalities. These studies highlight the importance of personalized treatment plans tailored to each child's unique dental needs. Veneers in pediatric dentistry offer durable and aesthetic solutions, often with minimal tooth preparation, making them suitable for young patients. Through case studies, dental professionals can showcase successful outcomes and educate parents about the potential advantages of veneers in enhancing their child's dental health and confidence.
H. pylori Treatment with PYELRA®: Best Practices
PYLERA® is a medication used for the treatment of Helicobacter pylori (H. pylori) infection, a common cause of stomach ulcers and gastritis. It contains a combination of three active ingredients: bismuth subcitrate potassium, metronidazole, and tetracycline. This combination works synergistically to eradicate H. pylori bacteria and reduce associated symptoms. Treatment with PYLERA® typically involves taking multiple capsules four times a day for a specified duration, as prescribed by a healthcare provider. It is important to follow the treatment regimen as directed and to discuss potential side effects
Inflammatory Bowel Disorders: Types
Crohn's disease is a type of IBD that can affect any part of the digestive tract, causing inflammation and ulcers. It commonly involves the end of the small intestine (ileum) and the beginning of the large intestine (colon). Ulcerative colitis is characterized by inflammation and ulcers in the lining of the large intestine (colon) and rectum. It typically starts in the rectum and can extend continuously into the colon. Some cases of IBD cannot be clearly classified as Crohn's disease or ulcerative colitis due to overlapping features or atypical presentations. This is referred to as indeterminate colitis.Microscopic colitis includes two subtypes: collagenous colitis and lymphocytic colitis. These conditions are characterized by chronic inflammation of the colon lining visible only under a microscope. While primarily known for causing mouth sores and skin lesions, Behçet's disease can also involve the gastrointestinal tract, leading to ulcers and inflammation resembling Crohn's disease.
Amenorrhea: Clinical Features & Treatment
Amenorrhea refers to the absence of menstrual periods in women of reproductive age and can be classified as either primary or secondary. Clinical features of amenorrhea may include hot flashes, vaginal dryness, breast changes, headaches, and hair loss, depending on the underlying cause such as hormonal imbalances, stress, or anatomical abnormalities. Diagnosis involves a thorough medical history, physical examination, and tests including hormone levels (e.g., FSH, LH, estradiol, thyroid function tests) and imaging studies (e.g., ultrasound, MRI). Treatment depends on the cause and may include lifestyle modifications, hormone replacement therapy, medications to induce ovulation, or surgical intervention in cases of structural abnormalities. Management aims to address underlying factors, restore menstrual function, and address any associated symptoms or complications of amenorrhea. Regular follow-up and monitoring are essential to assess treatment efficacy and address any new concerns or changes in symptoms.
Osteoporosis: Basic Facts
Postpartum hemorrhage (PPH) is a significant complication following childbirth, characterized by excessive bleeding within 24 hours of delivery. It's a leading cause of maternal mortality globally. PPH can occur due to various factors, including uterine atony (failure of the uterus to contract), trauma during childbirth, retained placental tissue, or coagulation disorders. Prompt recognition and intervention are crucial to prevent severe consequences. Management typically involve uterine massage, administration of uterotonic medications, uterine artery embolization, or, in severe cases, surgical interventions like hysterectomy. Timely and effective management strategies are essential to reduce maternal morbidity and mortality associated with PPH. Osteoporosis is a progressive bone disease characterized by decreased bone density and structural deterioration, leading to an increased risk of fractures, particularly in the spine, hips, and wrists. It often develops silently over years, with no symptoms until a fracture occurs. Factors such as aging, hormonal changes, inadequate nutrition (especially calcium and vitamin D deficiency), sedentary lifestyle, and certain medications contribute to its development. Prevention and management strategies include weight-bearing exercises, adequate calcium and vitamin D intake, lifestyle modifications to reduce risk factors, and sometimes medication to strengthen bones and reduce fracture risk. Early detection through bone density testing and proactive intervention are crucial in mitigating its impact on individuals' health and quality of life.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr Aruna Reddy's Talks on Assimilate
- 0
A teratogen is an agent that can disturb the development of the embryo or Fetus. The clinical consequences of drug teratogens lead to developmental defects in humans. Defects may be due to genetic, environmental, or unknown causes. Drug use is an uncommon cause of birth defects, but certain medications can increase the risk of developing a birth defect. Join the Case Based discussion with Dr Aruna Reddy Senior Gynecologist and Head OBG Department to have an exclusive learning on Teratology and drugs in Pregnancy.
- 0
A teratogen is an agent that can disturb the development of the embryo or Fetus. The clinical consequences of drug teratogens lead to developmental defects in humans. Defects may be due to genetic, environmental, or unknown causes. Drug use is an uncommon cause of birth defects, but certain medications can increase the risk of developing a birth defect. Join the Case Based discussion with Dr Aruna Reddy Senior Gynecologist and Head OBG Department to have an exclusive learning on Teratology and drugs in Pregnancy.
- 0
A teratogen is an agent that can disturb the development of the embryo or Fetus. The clinical consequences of drug teratogens lead to developmental defects in humans. Defects may be due to genetic, environmental, or unknown causes. Drug use is an uncommon cause of birth defects, but certain medications can increase the risk of developing a birth defect. Join the Case Based discussion with Dr Aruna Reddy Senior Gynecologist and Head OBG Department to have an exclusive learning on Teratology and drugs in Pregnancy.